Refine
Has Fulltext
- yes (900) (remove)
Year of publication
- 2014 (900) (remove)
Document Type
- Journal article (445)
- Doctoral Thesis (363)
- Complete part of issue (49)
- Review (9)
- Working Paper (8)
- Study Thesis (term paper) (7)
- Book article / Book chapter (5)
- Conference Proceeding (3)
- Preprint (3)
- Book (2)
Keywords
- Würzburg (48)
- University (47)
- Universität (47)
- Wuerzburg (47)
- Wurzburg (47)
- gene expression (12)
- Maus (11)
- T-Lymphozyt (10)
- expression (10)
- Rezension (8)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (123)
- Graduate School of Life Sciences (62)
- Universität - Fakultätsübergreifend (50)
- Physikalisches Institut (38)
- Medizinische Klinik und Poliklinik I (35)
- Institut für Psychologie (34)
- Medizinische Klinik und Poliklinik II (34)
- Neurologische Klinik und Poliklinik (27)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (26)
- Institut für Molekulare Infektionsbiologie (25)
Schriftenreihe
Sonstige beteiligte Institutionen
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (3)
- Röntgen Center for Complex Material Systems (RCCM), Am Hubland, 97074 W¨urzburg, Germany (2)
- Universitätsklinikum Münster (2)
- Wilhelm-Conrad-Röntgen-Forschungszentrum für komplexe Materialsysteme (2)
- Auftrag der Rummelsberger Dienste für Menschen mit Behinderung gGmbH; Aktion Mensch (1)
- Badisches Landesmuseum Karlsruhe (1)
- CBIO, University of Cape Town, South Africa (1)
- Centre for Political Studies, Jawaharlal Nehru University, New Delhi (1)
- Comprehensive Hearing Center, Department of ORL, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Würzburg, Germany (1)
- DLR (1)
ResearcherID
- I-5818-2014 (1)
High resolution Fourier transform mass spectrometry (HRFTMS) and nuclear magnetic resonance (NMR) spectroscopy were employed as complementary metabolomic tools to dereplicate the chemical profile of the new and antitrypanosomally active sponge-associated bacterium Actinokineospora sp. EG49 extract. Principal Component (PCA), hierarchical clustering (HCA), and orthogonal partial least square-discriminant analysis (OPLS-DA) were used to evaluate the HRFTMS and NMR data of crude extracts from four different fermentation approaches. Statistical analysis identified the best culture one-strain-many-compounds (OSMAC) condition and extraction procedure, which was used for the isolation of novel bioactive metabolites. As a result, two new O-glycosylated angucyclines, named actinosporins A (1) and B (2), were isolated from the broth culture of Actinokineospora sp. strain EG49, which was cultivated from the Red Sea sponge Spheciospongia vagabunda. The structures of actinosporins A and B were determined by 1D- and 2D-NMR techniques, as well as high resolution tandem mass spectrometry. Testing for antiparasitic properties showed that actinosporin A exhibited activity against Trypanosoma brucei brucei with an IC₅₀ value of 15 µM; however no activity was detected against Leishmania major and Plasmodium falciparum, therefore suggesting its selectivity against the parasite Trypanosoma brucei brucei; the causative agent of sleeping sickness.
The diversity of actinomycetes associated with marine sponges collected off Fsar Reef (Saudi Arabia) was investigated in the present study. Forty-seven actinomycetes were cultivated and phylogenetically identified based on 16S rRNA gene sequencing and were assigned to 10 different actinomycete genera. Eight putatively novel species belonging to genera Kocuria, Mycobacterium, Nocardia, and Rhodococcus were identified based on sequence similarity values below 98.2% to other 16S rRNA gene sequences available in the NCBI database. PCR-based screening for biosynthetic genes including type I and type II polyketide synthases (PKS-I, PKS-II) as well as nonribosomal peptide synthetases (NRPS) showed that 20 actinomycete isolates encoded each at least one type of biosynthetic gene. The organic extracts of nine isolates displayed bioactivity against at least one of the test pathogens, which were Gram-positive and Gram-negative bacteria, fungi, human parasites, as well as in a West Nile Virus protease enzymatic assay. These results emphasize that marine sponges are a prolific resource for novel bioactive actinomycetes with potential for drug discovery.
Die vorliegende Arbeit wurde im Rahmen eines interdisziplinären Forschungsprojektes der Universitätsklinik Würzburg verfasst (IZKF-Studiennr. F-164, CFCW-Projekt).
Ziel dieser Arbeit war es, explorativ zu untersuchen, inwieweit ein Lagerungsplagiozephalus (LP) die sprachlich-kognitive und motorische Entwicklung eines Säuglings/ Kindes beeinflusst und ob es Hinweise auf eine Auswirkung der Dauer der Therapie mittels Kopforthese auf die frühkindliche Entwicklung gibt. Sie liefert erstmalig Untersuchungsdaten zur vorsprachlichen und frühen sprachlichen Entwicklung von Säuglingen mit LP.
Das Probandenkollektiv bestand aus 71 Probanden (Plagiozephalus mit Helmtherapie (PMH)-Gruppe: N=36, Kontrollgruppe (KG): N=35). Im Alter von zwölf Monaten wurde die Sprachleistung aller Probanden mithilfe des ELFRA-1 eingeschätzt. Zudem wurden die Ergebnisse der deutschen Fassung der BSID II vom sechsten und zwölften Lebensmonat herangezogen. Um den Effekt der Helmtherapie auf die Entwicklung der Kinder mit LP zu berücksichtigen, fand eine Korrelation zwischen der Tragedauer und sprachproduktiven, sprachperzeptiven, gestischen, (fein-)motorischen und kognitiven Leistungen der Probanden statt. Ein maskierender Einfluss des Co-Faktors SLI-Risiko auf die Befunde konnte ausgeschlossen werden.
Zusammengefasst zeigen die hier untersuchten Säuglinge mit LP im Alter von sechs Monaten statistisch gerade signifikant schlechtere motorische Fähigkeiten als Säuglinge mit normaler Kopfform. Im Alter von zwölf Monaten holen sie diese Defizite jedoch auf und sind teilweise sogar motorisch geschickter als die Vergleichsgruppe. Die kognitive Entwicklung von Kindern mit LP scheint nicht verzögert zu sein, wie in der Fachliteratur postuliert.
In den Analysen zeigte sich kein signifikanter Zusammenhang zwischen der Helmtragedauer und den sprachlichen (ELFRA-1) und kognitiven (BSID: MDI 12 Monate) Fähigkeiten der Probanden mit LP. Die motorischen Fähigkeiten (BSID: PDI 12 Monate) zeigten einen statistisch signifikanten Zusammenhang zur Tragedauer der Kopforthese. Je länger der Helm getragen wurde, desto besser fielen die motorischen Leistungen der Probanden im Alter von zwölf Monaten aus.
Zusätzlich wurden Vokalisationen einer Untergruppe (High-Contrast-Gruppe (HC), N=20) im Hinblick auf melodische Variationsfähigkeiten im sechsten Lebensmonat untersucht. Dazu wurden die digitalen Lautaufnahmen im Säuglingslabor des ZVES an der Poliklinik für Kieferorthopädie editiert und mithilfe spezifischer Analyseprogramme quantitativ analysiert. Die Säuglinge mit LP wiesen genauso variantenreiche Melodien in ihren Vokalisationen auf wie die Säuglinge der Kontrollgruppe. Spätere Sprachauffälligkeiten würden sich bereits in diesen vorsprachlichen Fähigkeiten manifestieren.
Auch wenn zukünftige Studien bestätigen, dass ein LP – entgegen den Erkenntnissen anderer Autoren (Korpilahti et al. 2012, Speltz et al. 2010 u.a.) – keine kognitiven Beeinträchtigungen zur Folge hat, ist die Therapie dieser Schädelasymmetrie auf psychosozialer Ebene und wegen möglicher Auswirkungen auf das maxillomandibuläre System zu befürworten (Meyer-Marcotty et al. 2012).
Die vorliegende Arbeit beschäftigt sich mit der Rolle der gestielten Lappen, am Beispiel des Acromiopectoral- und Pectoralis-Major-Lappens, in der modernen
Mund-, Kiefer-, Gesichtschirurgie in einer Ära, in der mikrochirurgisch revaskularisierten, freien Transplantaten meist der Vorzug gegeben wird.
Insbesondere wird auf die Einheilung und Resensibilisierung des Acromiopectoral- und Pectoralis-Major-Lappens in der Empfängerregion des Kopf-/Halsbereiches eingegangen. Es wurde die Lebensqualität der Patienten anhand von verschiedenen Parametern wie Nahrungsaufnahme, Sprachvermögen, Beschwerden und Ästhetik beurteilt.
Des Weiteren wurde die objektive und subjektive Morbidität der Spenderregion untersucht. Es wurde geprüft, inwieweit die Entnahme der Lappen die Funktion, die Sensibilität und die Ästhetik des Schulter- und Brustbereiches beeinflussen.
Anhand einer retrospektiven Datenauswertung von 30 Patienten werden die Unterschiede in den Indikationsbereichen, Komplikationsraten und Einheilraten der beiden Lappen im Zeitraum von 2000 bis 2010 aufgezeigt.
Merkel Cell Carcinoma (MCC) is a rare and highly aggressive neuroendocrine skin cancer for which no effective treatment is available. MCC represents a human cancer with the best experimental evidence for a causal role of a polyoma virus. Large T antigens (LTA) encoded by polyoma viruses are oncoproteins, which are thought to require support of cellular heat shock protein 70 (HSP70) to exert their transforming activity. Here we evaluated the capability of MAL3-101, a synthetic HSP70 inhibitor, to limit proliferation and survival of various MCC cell lines. Remarkably, MAL3-101 treatment resulted in considerable apoptosis in 5 out of 7 MCC cell lines. While this effect was not associated with the viral status of the MCC cells, quantitative mRNA expression analysis of the known HSP70 isoforms revealed a significant correlation between MAL3-101 sensitivity and HSC70 expression, the most prominent isoform in all cell lines. Moreover, MAL3-101 also exhibited in vivo antitumor activity in an MCC xenograft model suggesting that this substance or related compounds are potential therapeutics for the treatment of MCC in the future.
Virotherapy on the basis of oncolytic vaccinia virus (VACV) infection is a promising approach for cancer therapy. In this study we describe the establishment of a new preclinical model of feline mammary carcinoma (FMC) using a recently established cancer cell line, DT09/06. In addition, we evaluated a recombinant vaccinia virus strain, GLV-5b451, expressing the anti-vascular endothelial growth factor (VEGF) single-chain antibody (scAb) GLAF-2 as an oncolytic agent against FMC. Cell culture data demonstrate that GLV-5b451 virus efficiently infected, replicated in and destroyed DT09/06 cancer cells. In the selected xenografts of FMC, a single systemic administration of GLV-5b451 led to significant inhibition of tumor growth in comparison to untreated tumor-bearing mice. Furthermore, tumor-specific virus infection led to overproduction of functional scAb GLAF-2, which caused drastic reduction of intratumoral VEGF levels and inhibition of angiogenesis.
In summary, here we have shown, for the first time, that the vaccinia virus strains and especially GLV-5b451 have great potential for effective treatment of FMC in animal model.
Spatially restricting cAMP production to discrete subcellular locations permits selective regulation of specific functional responses. But exactly where and how cAMP signaling is confined is not fully understood. Different receptors and adenylyl cyclase isoforms responsible for cAMP production are not uniformly distributed between lipid raft and non-lipid raft domains of the plasma membrane. We sought to determine the role that these membrane domains play in organizing cAMP responses in HEK293 cells. The freely diffusible FRET-based biosensor Epac2-camps was used to measure global cAMP responses, while versions of the probe targeted to lipid raft (Epac2-MyrPalm) and non-raft (Epac2-CAAX) domains were used to monitor local cAMP production near the plasma membrane. Disruption of lipid rafts by cholesterol depletion selectively altered cAMP responses produced by raft-associated receptors. The results indicate that receptors associated with lipid raft as well as non-lipid raft domains can contribute to global cAMP responses. In addition, basal cAMP activity was found to be significantly higher in non-raft domains. This was supported by the fact that pharmacologic inhibition of adenylyl cyclase activity reduced basal cAMP activity detected by Epac2-CAAX but not Epac2-MyrPalm or Epac2-camps. Responses detected by Epac2-CAAX were also more sensitive to direct stimulation of adenylyl cyclase activity, but less sensitive to inhibition of phosphodiesterase activity. Quantitative modeling was used to demonstrate that differences in adenylyl cyclase and phosphodiesterase activities are necessary but not sufficient to explain compartmentation of cAMP associated with different microdomains of the plasma membrane.
Assessing particle deposition in a representative in vitro model of the rat respiratory tract
(2014)
The aim of this thesis was to develop an in vitro model (IVR) of the rat lung for the purpose of investigating the deposition of drug particles in the rat airways. The model attempted to account for the affect of drug product characteristics and physiological parameters on deposition in the lungs. In addition, the model outputs were compared with in vivo lung deposition results from live rats and in silico predictions using published computer model of lung deposition in pre-clinical species.
Initial work focussed on developing an aerosol exposure system capable of dosing small rodent to a range of airborne test materials. The system consists of two main parts; a fluidised bed aerosol generator and connection of the generator output to a nose only exposure chamber capable of accommodating 12 small animals in a single layer. In addition, an aerodynamic particle spectrometer (APS) was installed for continuously measuring the size distribution and airborne concentration of aerosol particles generated in the exposure chamber. System validation showed acceptable degree of variation of the test material tested, Fluorescent Microspheres (FMS) throughout the exposure chamber (CV < 15.0%). Particle size (MMAD ± GSD) using the APS was shown to be stable throughout the exposure periods.
The IVR model developed in this project was based on a number of euthanased (n=7), female Sprague-Dawley rats (weight: 372 ± 56 g), which underwent high-resolution micro-CT scans. The physical model consisted of five sub sections; Extra-Thoracic region containing the snout and nasophyarynx, trachea-bronchial region containing the trachea, bronchi, and bronchioles. All sections of the model were attached to one another in numerical order and housed within a containment unit. At the rear end of the cast, a flexible diaphragm was attached in order to collect the fraction of inhaled particles exiting the TB section and possibly reaching the lung, referred to as the Post-TB section.
A study was conducted to assess the influence of inhalation parameters such as the breathing frequency and tidal volume on total and regional dose distribution using FMS as test material. The major finding of this study was the demonstration of the model sensitivity to changes in breathing parameters especially respiratory frequency, where the data showed increased deposition in the peripheral regions of the model with decreased respiratory frequency. Other studies assessed the effect of particle characteristics on deposition on the IVR model, such as particle size, dose increase and formulation changes.
The results assessing particle size effect showed a slightly higher deposition levels for the 4µm sized particles versus 2µm sized particles in the head region; 90.8 ± 3.6% and 88.2 ± 6.6%. However, this difference did not reach statistical significance (P> 0.05) probably due to the polydispersity of aerosolised FMS particles. In addition, the regional deposition analysis showed an increased lung peripheral deposition with the smaller particles. In addition, the model was shown to be sensitive to changes in formulation composition mediated by inclusion of MgSt.
The next stage of work was to validate the model in terms of comparison with lung deposition for in vivo rats. For lung deposition comparison, the absolute amount deposited in the IVR lung model (expressed as µg/kg) was shown to have a reasonably strong correlation with in vivo lung concentration measures (µg/kg); R2= 0.66, P < 0.05. Compounds were predicted well and within 2-folds of the measured lung deposition values. However, knowing the variability in biological systems and the multiple components required to estimate lung doses, predictions within 2-fold of the measured values would seem reasonable
In terms of comparison with in silico model predictions using MPPD, similar deposition levels were noted between the two models, particularly when the data was expressed as percentage of total particles inhaled. The data showed the highest deposition levels were noted in the head region (> 80%) and less than 5.0% deposition for the peripheral lung fractions.
With regards to using the IVR model to assess the relationship between dose, particle size and efficacy, an in vivo study using FP with different particle sizes (2.0 and 4.0 µm) but same doses ( 100 and 1000 µg/kg). This study demonstrated that exposure of rat to FP powder resulted in a dose-dependent inhibition of neutrophils in BAL fluids. However, a clear difference in neutrophils suppression was demonstrated for equivalent doses but different particle sizes of FP, where the smaller FP particles (2.0 µm) induced a greater level of neutrophils suppression in comparison with larger FP particles (4.0 µm). In addition, a reasonably good correlation for the relationship between lung deposition in the IVR model and a neutrophils suppression level was demonstrated. Furthermore this data support the hypothesis that regional deposition is an important determinant in efficacy. Therefore, this suggests that the IVR model may be a useful as a tool to describe in vivo efficacy with in vitro data. However, further studies should be conducted to evaluate the validity of this model and relationship.
The IVR model has a number of important limitations. First, the model is based on scans up to generation four of the rat respiratory tract as this represented the limits of the micro-CT scanning technology at the time of this study. Therefore deposition in the deeper region of the lung may not be reflected precisely in the IVR model. Second, the regional deposition data generated using the model tended to show an overestimation of deposition in head region and an underestimation of deposition in the peripheral regions of the lung, in comparison with in vivo lung deposition data. Third, the current model does not take into account lung clearance. However, the amount of the drug present in the in vivo lungs is dependent on numerous physiological processes such as dissolution, passive or active absorption into the systemic circulation, binding to lung tissue and mucociliary clearance. Consequently, the results generated using this IVR model for drug molecules with high lung clearance rate should be treated with some caution.
Future work extending this research could go in a number of directions. In this research, a representative model of the rat respiratory tract was constructed from analysis of imaging data from a number of euthanised Sprague-Dawley rats. This model represented the “average respiratory tract” in terms of dimensions of Sprague-Dawley rats. However, there is considerable variability in the airway dimensions between rats. This variability encompasses a number of factors such as the strains of rats, sex and age, and disease state. Thus, it may be possible to produce a small number of airway models to represent small and large rats and scaled to represent the extrathoracic and peripheral regions based on literature reports of their dimensions in different rat populations. This approach will then enable the effect of intersubject airway dimensions for different rat populations on aerosol deposition to be thoroughly examined.
In addition, due to the limitation of the micro-CT technology used to construct the physical IVR model, detailed morphology only up to generation 4 were captured. However, recent advances in MRI technology, such as the use of in situ-MRI based scanning technology have enabled rat airway morphometry to be extended to 16 airway generation. This coupled with improvements in the resolutions of rapid-prototyping process means it may be possible to construct a rat model that reflects the in vivo lung morphology more accurately, and thus enable greater understanding of the link between aerosol deposition and airway geometry.
In conclusion, a model cast of the rat lung was developed and validated to allow the deposition of inhaled particles in the rat lung to be investigated. The model may be used to estimate the lung concentration in vivo rats in preference to exposure concentration measurements based on filter samples which have been shown to be a poor indicator of the lung concentration immediately after exposure. In addition, the model has the potential to be used along with live rats in an inhalation rig in pulmonary pharmaceutics research and may facilitate in development of inhaled formulations to target specific regions within the lung as well as screening of inhaled drugs in preclinical setting.
The composition of stable-isotope labelled isotopologues/isotopomers in metabolic products can be measured by mass spectrometry and supports the analysis of pathways and fluxes. As a prerequisite, the original mass spectra have to be processed, managed and stored to rapidly calculate, analyse and compare isotopomer enrichments to study, for instance, bacterial metabolism in infection. For such applications, we provide here the database application ‘Isotopo’. This software package includes (i) a database to store and process isotopomer data, (ii) a parser to upload and translate different data formats for such data and (iii) an improved application to process and convert signal intensities from mass spectra of \(^{13}C\)-labelled metabolites such as tertbutyldimethylsilyl-derivatives of amino acids. Relative mass intensities and isotopomer distributions are calculated applying a partial least square method with iterative refinement for high precision data. The data output includes formats such as graphs for overall enrichments in amino acids. The package is user-friendly for easy and robust data management of multiple experiments.